Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 2Terminated 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gynecologic 3

Conditions

Carcinoma, Ovarian Epithelial 3

Interventions

Paclitaxel 233Carboplatin 217Bevacizumab 139Cisplatin 136pembrolizumab 89Gemcitabine 69olaparib 54Docetaxel 47Topotecan 44Radiotherapy 43liposomal doxorubicin 41Taxes 41niraparib 38Cyclophosphamide 36Doxorubicin 30Drug Therapy 29Letrozole 28Nivolumab 27Magnetic Resonance Spectroscopy 25Immunoglobulin G 25Disulfides 24Oxaliplatin 23Albumin-Bound Paclitaxel 23durvalumab 22apatinib 21Etoposide 21Brachytherapy 21lenvatinib 20camrelizumab 20Specimen Handling 20

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × CCV-AV protocol × Gynecologic × Clear all
NCT01617629 2017-12-08

CAN-003X

Prima BioMed Ltd

Phase 2 Completed
9 enrolled 7 charts
Gynecologic

Carcinoma, Ovarian Epithelial

NCT01068509 2017-05-11

Ovarian Cancer Vaccine for Patients in Remission

Prima BioMed Ltd

Phase 2 Completed
63 enrolled 9 charts
Gynecologic

Carcinoma, Ovarian Epithelial

NCT01521143 2016-12-14

CANVAS

Prima BioMed Ltd

Phase 2 Terminated
91 enrolled 5 charts
Gynecologic

Carcinoma, Ovarian Epithelial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡